Bli medlem
Bli medlem

Du är här

2020-08-18

ExpreS2ion Biotechnologies: ExpreS2ion appoints new CFO

Mr. Alexander (44) joins ExpreS[2]ion with over 20 years of experience in investment markets, investor communications, corporate strategy and business development. He joins ExpreS[2]ion from Danske Bank Asset Management, where he was responsible for the Fixed Income & Credit Advisory & Product Specialist function. He has held previous positions at Danske Capital as Head of North America, and at J.P. Morgan in New York City as Vice President, Strategy & Business Development, and Vice President, Equity Research. He has an MBA from The Wharton School of the University of Pennsylvania in Philadelphia, PA, USA, and a B.Sc. in Industrial Management with a minor in Biological Sciences from Purdue University in West Lafayette, Indiana, USA.

ExpreS[2]ion's CEO Bent Frandsen comments:

"I am very pleased that Keith has decided to join the next stage of ExpreS[2]ions journey. His experience will be a great asset as we move forward with the strategy transformation we announced in the beginning of 2020. The first order of business is to support with financial aspects in ExpreS[2]ion's transformation to a pipeline-driven business model, including all the requirements needed to be ready to exercise our option on AV001."

Certified Adviser

Svensk Kapitalmarknadsgranskning AB

Telefon: +46 11 32 30 732

E-post: ca@skmg.se

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.